IVA · Inventiva S.A. · Metrics
$3.69
+0.03 (+0.68%)
At close · Oct 27
Return incl. dividend (before tax)
Q4 2025 earnings call transcript
Market Cap
$864.57M
Shares
236.22M
Volume · Oct 27
1.78M
Avg daily vol (3M)
1.89M
IVA metrics
58 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$3.69
Market cap
$864.57M
Price action
20 metricsPrice change (1W)
+22.8%
Price change (30D)
+3.7%
Price change (3M)
-20.4%
Price change (6M)
-28.7%
Price change (YTD)
-21.3%
Price change (1Y)
-41.0%
Trailing year
Price change (5Y)
-75.3%
52-week high
$7.15
52-week low
$2.87
Change from 52-week high
-48.8%
Change from 52-week low
+27.5%
Annualized volatility
72.4%
Annualized volatility (3M)
63.6%
Beta
0.9
RSI (14D)
54.9
Price vs SMA 50
-6.1%
Price vs SMA 200
-25.6%
Avg volume (3M)
1.88M
Relative volume
1.8
Average dollar volume
$6.92M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
236.22M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
15,125.9×
reciprocal yield 0.0%
P / book
12.8
reciprocal yield 7.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-09-28
Profitability
9 metricsGross margin
—
Operating margin
-302,981.6%
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$148.46M
Net income (TTM)
−$338.62M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-51.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$57,158
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+102.0%
Year over year · more shares
Revenue CAGR (3Y)
-28.3%
Revenue CAGR (5Y)
+64.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-173.8%
Debt / equity
—
Current ratio
3.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-0.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$116.55M
Total assets
$286.81M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$112.68M
Capital expenditures (TTM)
—
R&D (TTM)
$103.11M
SG&A (TTM)
—
Stock compensation (TTM)
$42.37M
R&D / revenue
180,389.8%
Stock compensation / revenue
74,126.5%
Ownership (13F)
9 metrics13F filers
88
13F filer change QoQ
+23
Institutional ownership
35.8%
Conviction holders (share of 13F filers)
5.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+65.1%
Holder tenure
3.2
Price vs estimated holder cost
-25.6%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
3.5%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
52 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—